Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10303060 | Journal of Substance Abuse Treatment | 2015 | 6 Pages |
Abstract
Although research has generally supported the validity of substance use self-reports, some patients deny urine-verified substance use. We examined the prevalence and patterns of denying urinalysis-confirmed opioid use in a sample of prescription opioid dependent patients. We also identified characteristics associated with denial in this population of increasing public health concern. Opioid use self-reports were compared with weekly urinalysis results in a 12-week multi-site treatment study for prescription opioid dependence. Among those who used opioids during the trial (n = 246/360), 44.3% (n = 109) denied urinalysis-confirmed opioid use, although usually only once (78%). Overall, 22.9% of opioid-positive urine tests (149/650) were denied on self-report. Multivariable analysis found that initially using opioids to relieve pain was associated with denying opioid use. These findings support the use of both self-reports and urine testing in treating prescription opioid dependence.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
E. Yvette B.S., Margaret L. Ph.D., R. Kathryn Ph.D., Katherine A. B.A., Hilary S. M.D., Ph.D., Garrett M. Sc.D., Roger D. M.D.,